Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetic disorders causing abnormal LDL-cholesterol levels].

T Murayama1

  • 1Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The vinylogous Catellani reaction: a combined computational and experimental study.

Chemical science·2018
Same author

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG.

Leukemia·2017
Same author

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.

Oncogene·2016
Same author

Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation.

Hematology (Amsterdam, Netherlands)·2016
Same author

New Monoterpentriols from the Fruiting Body of Flammulina velutipes.

Bioscience, biotechnology, and biochemistry·2016
Same author

Ipragliflozin as an Initial Therapy in Drug Naïve Subjects with Type 2 Diabetes.

Drug research·2016
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Inherited disorders affecting LDL-cholesterol levels, such as familial hypercholesterolemia, increase heart disease risk. Understanding these genetic conditions and their animal models is key to developing new therapies like gene therapy.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Metabolic Disorders

Context:

  • Epidemiological studies link serum LDL-cholesterol to ischemic heart disease incidence.
  • Lipid intervention trials demonstrate that lowering LDL-cholesterol prevents cardiac events.
  • Genetic factors significantly influence serum lipid profiles and cardiovascular health.

Purpose:

  • To review inherited disorders causing abnormal serum LDL-cholesterol levels.
  • To discuss the mechanisms and animal models of these genetic lipid disorders.
  • To highlight the need for advanced therapeutic strategies, including gene therapy.

Summary:

  • Familial hypercholesterolemia, familial ligand-defective apolipoprotein B100, familial combined hyperlipidemia, and cholesterol ester storage disease elevate serum LDL-cholesterol.

Related Experiment Videos

  • Abetalipoproteinemia and familial hypobetalipoproteinemia decrease serum LDL-cholesterol.
  • Genetic engineering has advanced the understanding and modeling of these inherited conditions.

    • Impact:

    • These genetic disorders can lead to atherosclerosis and psychoneurological diseases.
    • Current fundamental therapies are insufficient, underscoring the need for novel treatments.
    • Gene therapy presents a potential future therapeutic avenue for managing these inherited lipid disorders.